APA

Iliuta I., Beauregard J., Couture F., Douville P. & Mac-Way F. (20160223). Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. : Clinical nuclear medicine.

Chicago

Iliuta Ioan-Andrei, Beauregard Jean-Mathieu, Couture Félix, Douville Pierre and Mac-Way Fabrice. 20160223. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. : Clinical nuclear medicine.

Harvard

Iliuta I., Beauregard J., Couture F., Douville P. and Mac-Way F. (20160223). Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. : Clinical nuclear medicine.

MLA

Iliuta Ioan-Andrei, Beauregard Jean-Mathieu, Couture Félix, Douville Pierre and Mac-Way Fabrice. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. : Clinical nuclear medicine. 20160223.